NASDAQ: GMAB
Genmab A Stock Ownership - Who owns Genmab A?

Insider buying vs selling

Have Genmab A insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when GMAB insiders and whales buy or sell their stock.

GMAB Shareholders

What type of owners hold Genmab A stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Parbio0.02%13,133$456.37kInstitution
Paradigm Biocapital Advisors LP0.02%13,133$456.37kInstitution
Orbis Allan Gray Ltd0.02%11,368$395.04kInstitution
Orbilg0.02%11,368$395.04kInstitution
Allian0.01%8,645$300.41kInstitution
Alliancebernstein LP0.01%8,644$300.38kInstitution
Deerfield Management Company LP0.01%6,865$238.56kInstitution
Deerfi0.01%6,865$238.56kInstitution
Deetra0.01%5,650$196.34kInstitution
Deep Track Capital LP0.01%5,650$196.34kInstitution

1 of 3

GMAB vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
GMAB0.16%0.00%
UTHR0.10%14.82%Net SellingNet Selling
BNTX0.02%31.79%Net SellingNet Selling
INCY0.10%28.09%Net SellingNet Selling
ROIV0.08%92.24%Net SellingNet Selling

Genmab A Stock Ownership FAQ

Who owns Genmab A?

Genmab A (NASDAQ: GMAB) is owned by 0.16% institutional shareholders, 0.00% Genmab A insiders, and 99.84% retail investors. Parbio is the largest individual Genmab A shareholder, owning 13,133.00 shares representing 0.02% of the company. Parbio's Genmab A shares are currently valued at $457.42k.

If you're new to stock investing, here's how to buy Genmab A stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.